Loading...
Oxaliplatin-Induced Immune-Mediated Thrombocytopenia: A Case Report
Oxaliplatin is a third-generation platinum derivative used for metastatic or advanced colorectal cancer treatment. Although myelosuppression is the most common cause of oxaliplatin-induced thrombocytopenia, rare cases of oxaliplatin-induced immune-mediated thrombocytopenia are reported. We report a...
Saved in:
| Published in: | Cancer Res Treat |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Korean Cancer Association
2015
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4614196/ https://ncbi.nlm.nih.gov/pubmed/25544580 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2014.052 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|